Onset and length are merely a perform of a toxin's molecular potency to the point of complete saturation of NMJs. Any number of BoNT?A molecules previous the point of saturation will then be unbound and clinically useless. Larger molecular potency may well enhance the quantity of adverse functions (AEs), but this is often dependent upon the method